focus -WSS

focus

author：comprehensive 2025-09-30 22:27:14 - browse：73

Dolly sheep — Alex Hogan/STAT, Getty Images

Dolly, the first animal to be cloned from an adult of its species, was born 20 years ago today at the Roslin Institute in Scotland. When her creators announced what they had done, it triggered warnings of rich people cloning themselves for spare parts, of tyrants cloning soldiers for armies, of bereaved parents cloning their dead child to produce a replacement — and promises that the technique would bring medical breakthroughs. Which raises some questions:

Why are there no human clones?

Because of scientific, ethical, and commercial reasons.

The scientists who created Dolly — named after Dolly Parton, naturally — removed the DNA from a sheep ovum, fused the ovum with a mammary epithelial cell from an adult “donor” sheep, and transplanted the result, now carrying DNA only from the donor, into a surrogate ewe. But that technique, called somatic cell nuclear transfer (SCNT), turned out not to be so easy in other species.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： NYU radiologists take on the challenge of expensive MRI machines

focus

WSS

Congress must reauthorize a committee to support older Americans

When prostate cancer spreads, where it goes matters

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

NVIDIA and Google execs on the future of AI and drug discovery

When prostate cancer spreads, where it goes matters

focus

focus

Why are there no human clones?

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

FDA's Woodcock to retire early next year

Sports medicine is finally prioritizing gender equality

Addiction experts warn against a second 'war on drugs'

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Psychedelics group wrestles with new pharma identity

With measles on the rise, a personal story of a devastating disease

At least 13 dead in Texas as scorching temps continue

With measles on the rise, a personal story of a devastating disease

focus

Wearables generate powerful data but its not useful to doctors, yet

Morphosys mixed study results for blood cancer drug

Solving academic medical centers' existential crisis

Cytokinetics CEO stresses company can launch heart drug on its own

Hospitals look to new technology to keep health care workers safe

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

knowledge

focus

focus

knowledge